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Summary
Epidemiological studies in humans have demonstrated a re-
lationship between pathological events during fetal devel-
opment and increased cardiovascular risk later in life and
have led to the so called “Fetal programming of cardiovas-
cular disease hypothesis”. The recent observation of gen-
eralised vascular dysfunction in young apparently healthy
children conceived by assisted reproductive technologies
(ART) provides a novel and potentially very important ex-
ample of this hypothesis. This review summarises recent
data in ART children demonstrating premature subclinical
atherosclerosis in the systemic circulation and pulmonary
vascular dysfunction predisposing to exaggerated hypoxia-
induced pulmonary hypertension. These problems appear
to be related to the ART procedure per se. Studies in ART
mice demonstrating premature vascular aging and arterial
hypertension further demonstrate the potential of ART to
increase cardiovascular risk and have allowed to unravel
epigenetic alterations of the eNOS gene as an underpin-
ning mechanism. The roughly 25% shortening of the life
span in ART mice challenged with a western style high-
fat-diet demonstrates the potential importance of these al-
terations for the long-term outcome. Given the young age
of the ART population, data on cardiovascular endpoints
will not be available before 20 to 30 years from now.
However, already now cohort studies of the ART popula-
tion are needed to early detect cardiovascular alterations
with the aim to prevent or at least optimally treat cardiovas-
cular complications. Finally, a debate needs to be engaged
on the future of ART and the consequences of its exponen-
tial growth for public health.
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Background
There is abundant evidence from epidemiological studies
that adverse events during early life are associated with in-
creased prevalence of cardiovascular disease later in life;
20 years ago Barker coined the term “Fetal programming
of cardiovascular diseases” to describe this phenomenon
[1–3]. While these earlier studies conducted in adults fo-
cused on clinical cardiovascular endpoints, more recent
work focused on alterations of the circulation that occur
many years before the clinical event and are already detect-
able during childhood (fig. 1) [4, 5]. This is of importance,
because the detection of subpopulations at risk at an early
stage may allow the prevention of future development of
cardiovascular diseases.
Recent data in young apparently healthy offspring of moth-
ers suffering from preeclampsia provide an example of this
shift of focus [6]. Epidemiological data show that pree-
clampsia is associated with an increased risk of cardiovas-
cular morbidity in the adult offspring [7, 8]. Based on these
data, we speculated that early predictors of future cardi-
Figure 1
Atherosclerosis burden starts early in life. Endothelial dysfunction,
arterial stiffening and structural alterations of the arterial wall
represent early steps in the development of atherosclerosis that are
already detectable in children known to be at increased
cardiovascular risk later in life.
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ovascular risk may already be detectable in young appar-
ently healthy offspring of mothers with preeclampsia. To
this end, we assessed flow mediated dilation and vascu-
lar stiffness in the systemic circulation, two established in-
dependent predictors of future cardiovascular risk [9, 10]
in offspring of preeclampsia and controls. Moreover, we
also assessed the pulmonary artery pressure response to
hypoxia in these two groups. In line with our hypothesis,
we found that young (14 years old) offspring of mothers
with preeclampsia display systemic and pulmonary vascu-
lar dysfunction. This vascular dysfunction was related to
preeclampsia itself, because siblings of offspring of moth-
ers with preeclampsia who were born after an uncomplic-
ated pregnancy showed normal vascular function [6]. Since
underpinning mechanisms are difficult to be investigated
in healthy young subjects, we next examined pulmonary
vascular function in offspring of restrictive diet pregnancy
(RDP) mice, a mouse model mimicking many aspects of
preeclampsia in humans. We found that pulmonary vascu-
lar function was defective and hypoxic pulmonary hyper-
tension exaggerated in offspring of RDP mice [11]. Epigen-
etic activity is increased towards the end of fetal develop-
ment (fig. 2, Panel A) and may be particularly vulnerable
to pathological insults during this critical period [12]. In
line with this hypothesis, we found that pulmonary vascu-
lar dysfunction in RDP mice was related to an epigenetic
mechanism [11].
Epigenetic mechanisms are involved
in fetal programming of vascular
dysfunction
The term “epigenetic” refers to mechanisms that regulate
gene expression without affecting the DNA sequence itself.
The most relevant epigenetic mechanisms include DNA
methylation and histone modification [13]. Increased DNA
methylation is associated with inhibition of transcription
(fig. 2, Panel B). In RDP mice, pulmonary vascular dys-
function and exaggerated hypoxic pulmonary hypertension
Figure 2
Role of epigenetic alterations in the fetal programming of vascular
dysfunction. Vulnerable periods during early life known to be
associated with fetal programming of cardiovascular disease
coincide with increased epigenetic activity (Panel A). Increased
DNA methylation inhibits transcription (Panel B). In mice conceived
by assisted reproductive technologies, DNA-methylation of the
eNOS gene was altered resulting in decreased eNOS transcription
in the vasculature and impaired vascular nitric oxide synthesis.
These problems translated into vascular dysfunction and arterial
hypertension (Panel C).
was associated with increased pulmonary DNA methyla-
tion [11]. These findings provided the first direct evidence
for an epigenetic mechanism underpinning pulmonary vas-
cular dysfunction induced by a pathological insult during
late fetal life. It appears possible that a similar mechanism
may be operational in preeclampsia-induced vascular dys-
function in the offspring in humans [12].
Figure 2 (Panel A) shows that in addition to the late fetal
phase, the early embryonic phase is also characterised by
increased epigenetic activity. Assisted reproductive techno-
logies (ART) allowed millions of infertile couples to have
children who now make up 2% to 4% of births in industri-
alised countries [14, 15]. ART implies multiple manipula-
tions of the embryo during this critical period where it may
be particularly susceptible to environmental alterations that
may induce epigenetic modifications [16]. In line with this
speculation, ART induces epigenetic alterations in the em-
bryo [17, 18] and is associated with an increased frequency
of rare diseases known to be related to an epigenetic mech-
anism [16, 19]. Based on these observations, we speculated
that ART induces vascular dysfunction in the offspring that
is related to an epigenetic mechanism.
In the following we will briefly review the data consistent
with this hypothesis.
ART induces vascular dysfunction in
the offspring
Due to the young age of the ART population in humans
(the first ART child was born in 1978) it is not known
yet whether ART is associated with increased risk for clin-
ical cardiovascular endpoints. However, there is abundant
evidence that in populations at risk, atherosclerosis already
starts in childhood many years before the first clinical event
occurs (fig. 1) [4, 5]. In humans several non-invasive tech-
niques allow detection of subclinical atherosclerosis.
To test our hypothesis, we have used the following three
methods to assess systemic vascular function and structure
in ART and matched control children.
Systemic endothelial dysfunction represents the first step
in the development of atherosclerosis and is already de-
tectable in apparently healthy children at increased cardi-
ovascular risk [4, 5, 9]. Systemic conduit artery endotheli-
al function can be assessed by determining the increase of
the brachial artery diameter evoked by reactive hyperemia
(flow-mediated vasodilation, FMD) using high-resolution
ultrasound and automatic wall tracking software [20]. Fig-
ure 3A shows that young children conceived by ART dis-
play systemic endothelial dysfunction [21]. Interestingly,
this impairment of endothelial function in ART children
was of similar magnitude as the one we previously ob-
served in offspring of mothers with preeclampsia [6].
In addition to endothelial dysfunction, stiffening of the vas-
culature also takes place during the early development of
atherosclerosis and represents an independent predictor of
future cardiovascular events in populations at risk [10, 22].
Exaggerated stiffening of the vasculature has been invari-
ably found in children suffering from conditions known
to predispose to premature cardiovascular morbidity and
mortality such as diabetes, dyslipidemia and hypertension
[23–25]. Carotid-femoral pulse wave velocity (PWV) is
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considered the gold standard to measure arterial stiffness in
humans [10]. We found that PWV was significantly faster
in ART children than in controls (7.8 ± 2.4 vs 6.5 ± 1.3 m/s;
P <0.001) [21].
Finally, atherosclerosis goes along with structural changes
of the vasculature. Measurement of carotid intima-media
thickness (IMT) by ultrasound is the most widely used non-
invasive method to assess structural changes of the system-
ic circulation. IMT is considered a surrogate marker of sub-
clinical atherosclerosis and increased IMT has been repor-
ted in children with familial hypercholesterinemia, arterial
hypertension and type 1 or 2 diabetes mellitus [26–31].
We found that carotid IMT was significantly greater in
ART than in control children [21]. In line with this finding,
Gratacos and colleagues recently reported increased aortic
IMT in utero and early after birth in ART children [32].
To test whether vascular dysfunction in ART children was
not limited to the systemic circulation but generalised, we
assessed pulmonary artery pressure responses to high-alti-
tude exposure, a maneuver designed to facilitate the detec-
tion of pulmonary vascular dysfunction [33, 34]. Figure 3
(Panel B) shows that in ART children vascular dysfunction
also affects the pulmonary circulation, as evidenced by ex-
aggerated hypoxic pulmonary hypertension at high altitude
[21]. Hypoxic pulmonary hypertension in ART children
was even more pronounced than in offspring of mothers
with preeclampsia, a condition known to be associated with
hypoxic pulmonary hypertension [6, 34]. We don’t know
yet how this pulmonary vascular dysfunction will evolve,
but it appears possible that the ART population may be at
increased risk for sustained pulmonary hypertension in dis-
ease states associated with chronic hypoxemia.
Taken together these findings demonstrate systemic and
pulmonary vascular dysfunction in ART children that is at
least of similar severity as the one observed in offspring of
mothers with preeclampsia, a population known to be at in-
creased cardiovascular risk later in life [7, 8].
Mechanisms underpinning ART-
induced vascular dysfunction
Evidence from studies in humans
Parent-related factors such as infertility, older age of the
mother necessitating to resort to ART and/or hormonal
stimulation of the ovulation in the mother could contribute
to vascular dysfunction in ART children. For example,
sterility could be associated with vascular dysfunction in
humans, a problem that could then be transmitted to the
offspring by ART. To test for this possibility, we assessed
systemic endothelial function (fig. 3, Panel C) and arterial
stiffness (fig. 3, Panel D) in sterile and fertile parents and
found that it was comparable in the two groups. In line with
this concept, vascular function was normal in siblings of
ART children who were conceived naturally [21].
Alternatively, the age of the parents could be a determinant
of vascular function in the offspring. This possibility is un-
likely, since in our study we found no relationship between
maternal age and vascular function of the progeny (fig. 3,
Panel E). Finally, stimulation of the ovulation did not ap-
pear to play a major role, since vascular function was nor-
mal in children conceived naturally during hormonal stim-
ulation of the ovulation in the mother (fig. 3, Panel F).
Taken together, these data in humans suggest that ART
per se is the main culprit and that parent-related factors
do not contribute significantly to vascular dysfunction in
ART children. However, the underlying mechanisms are
unknown and difficult to investigate in healthy children.
To this end we turned our attention to ART mice.
Evidence from studies in ART mice
Vascular dysfunction, arterial hypertension and shortened
life span in ART mice
We found that in ART mice endothelium-dependent mes-
enteric artery dilation was defective and carotid artery stiff-
ness increased (fig. 4, panel A+B) [35]. In ART mice, this
Figure 3
Flow-mediated vasodilation (FMD) of the brachial artery and right
ventricular to right atrial (RV-RA) pressure gradient in children
conceived by assisted reproductive technologies (ART), in offspring
of mothers suffering from preeclampsia and in age- and gender-
matched healthy control children (Panel A and B). FMD and pulse
wave velocity (PWV) in fertile parents of control children and of
sterile parents ART children (Panel C and D). Relationship between
maternal age and FMD in ART children (Panel E). FMD in control
children, ART children and children naturally conceived during
stimulation of the ovulation in the mother (Panel F). Data are
expressed as mean ± SEM. ANOVA and Bonferroni post-hoc test
(for Panel A, B and F).
Figure 4
Vascular function and arterial blood pressure in mice generated by
ART and control mice. Panel A shows acetylcholine-induced
mesenteric artery vasodilation, Panel B the carotid artery pressure-
diameter relationship, a proxy of vascular stiffness, Panel C shows
mean arterial blood pressure obtained by telemetry. Panel D shows
acetylcholine-induced mesenteric artery vasodilation in mice
conceived during stimulation of the ovulation in the mother and
control mice.
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defective vascular function in vitro translated into marked
arterial hypertension in vivo. (Figure 4, Panel C). These
data in mice further demonstrate the potential of ART to
cause premature vascular dysfunction and aging and arteri-
al hypertension. Moreover, and of potential importance for
the long-term outcome of the ART population in humans,
we observed a dramatic, roughly 25% shortening of the life
span in ART mice challenged with a western style high-fat
diet [35].
In addition, ART mice provided unique insight into mech-
anisms underpinning ART-induced vascular dysfunction
and premature mortality.
Underlying mechanisms
In humans it is difficult to completely exclude the possib-
ility that parental factors contribute to vascular dysfunction
in ART children (see above). The finding that in normal
mice, ART induces premature vascular aging and arteri-
al hypertension, however, provides strong additional evid-
ence for the concept that ART per se is the main culprit.
The findings in mice also strengthen the concept that hor-
monal stimulation of the ovulation in the mother per se is
not an important determinant of ART-induced vascular dys-
function, because endothelium-dependent vasodilation of
the mesenteric artery was normal in offspring of super-ovu-
lated mice (fig. 4, Panel D).
In offspring of RDP in mice, pulmonary vascular dysfunc-
tion is associated with altered lung DNA methylation sug-
gesting that epigenetic mechanism may be involved in the
fetal programming of the vascular system [11]. Moreover,
it is well established that epigenetic alterations can be
transmitted to the next generation [36, 37]. We, therefore,
assessed vascular function and blood pressure in offspring
of male ART mice mated with normal females. We found
vascular dysfunction and arterial hypertension in the pro-
geny that was comparable to the one observed in their fath-
ers [35]. In a next step, we then investigated the methyl-
ation of genes known to be important in the regulation of
systemic vascular function. We found that the methylation
of the promoter of the gene coding for endothelial nitric ox-
ide synthase (eNOS) was altered in the aorta of ART mice.
This dysmethylation had important consequences, as evid-
ence by decreased eNOS and eNOS RNA expression in the
vasculature and impaired vascular nitric oxide synthesis in
ART compared with control mice. Of note, dysmethylation
of the eNOS gene was not generalised, as evidenced by
normal methylation in the liver [35].
Taken together these findings indicate that in ART mice the
entire chain of events starting from the methylation of the
promoter of the eNOS gene and ending up in premature
vascular aging and arterial hypertension is altered (fig. 2,
Panel C).
To further test for the importance of this epigenetic mech-
anism we then assessed the effects of histone deacetylase-
inhibitor administration to ART mice. The rationale was
that histone deacetylase inhibitors (i.e. butyrate) are known
to reverse altered methylation and phenotypic changes in-
duced by pathological events during the fetal period [38].
In line with this concept, we found that butyrate adminis-
tration to male ART mice normalised methylation of the
eNOS gene and vascular function and prevented transmis-
sion of these problems to the progeny [35]. Collectively,
these data in mice demonstrate that ART-induced cardi-
ovascular alterations are related to an epigenetic mechan-
ism.
Finally, these studies in ART mice also provided insight in-
to the mechanisms underpinning these epigenetic and vas-
cular alterations. Culture media currently used for ART are
suboptimal, as evidenced by lower pregnancy rates and im-
paired growth of cultured embryos [39]. This problem may
be related to physical and chemical features of culture me-
dia that are different from those of human oviductal fluid.
Our data in mice indicate that shortening of the culture time
does not appear to be beneficial, since vascular dysfunc-
tion was comparable in embryos implanted at the 2–cell
stage and as blastocysts [35]. In line with this observa-
tion, altered methylation patterns and gene expression were
already detectable in 2-cell stage embryos [40]. Moreover,
there is evidence that suboptimal culture conditions in vitro
compromise the ability of the embryo to maintain genetic
imprinting [39]. Taken together, these findings suggest that
suboptimal culture conditions contribute to ART-induced
cardiovascular dysfunction. In line with this speculation,
preliminary data suggest that chemical modification of the
culture media may attenuate epigenetic alterations and vas-
cular dysfunction in ART mice [41].
Conclusion and future perspectives
The data presented in this review suggest that ART has lost
its innocence and represents a major novel cardiovascular
risk factor expected to be present in 2% to 4% of the pop-
ulation in industrialised countries and with the potential to
be transmitted to future generations (fig. 5). A major prob-
lem at this time is that given the young age of the ART pop-
ulation we do not know yet, and will not know before 20 to
30 years from now, how the consequences of ART-induced
premature atherosclerosis on cardiovascular endpoints (ar-
terial hypertension, stroke, myocardial infarction, hypox-
ic pulmonary hypertension and related morbidity and mor-
tality) will be. Extrapolation from young populations with
similar risk profile and known prevalence of cardiovascular
Figure 5
Potential factors involved in the development of ART-induced
vascular alterations. Parental and procedure-associated factors that
seem not to be major determinants of vascular changes are marked
in green, procedure-associated factors that may play a major role in
red.
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morbidity and mortality later in life suggest that they may
be important.
What can be done? First, for the already existing ART pop-
ulation there is a need for optimal medical care in order to
early detect cardiovascular alterations with the aim to pre-
vent, post-pone or at least optimally treat cardiovascular
complications.
(Note added in proof: Recent data indicate that antioxidant
administration to ART children improved NO bioavailab-
ility and vascular responsiveness suggesting that ART-in-
duced vascular dysfunction is subject to redox regulation
and reversible [42].)
In this regard, cohort studies of ART populations would be
very important. Second, there is an urgent need for a bet-
ter mechanistic understanding of ART-induced cardiovas-
cular alterations in order to find ways to prevent them in the
future. Third, society and politics need to engage a debate
now on the future of ART and the consequences of its ex-
ponential growth for public health. The impetus for starting
this debate is unlikely to come from the medico-industrial
ART complex; wait and see for another 20 or 30 years does
not appear to represent a valid option here.
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Figures (large format)
Figure 1
Atherosclerosis burden starts early in life. Endothelial dysfunction, arterial stiffening and structural alterations of the arterial wall represent early
steps in the development of atherosclerosis that are already detectable in children known to be at increased cardiovascular risk later in life.
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Figure 2
Role of epigenetic alterations in the fetal programming of vascular dysfunction. Vulnerable periods during early life known to be associated with
fetal programming of cardiovascular disease coincide with increased epigenetic activity (Panel A). Increased DNA methylation inhibits of
transcription (Panel B). In mice conceived by assisted reproductive technologies, DNA-methylation of the eNOS gene was altered resulting in
decreased eNOS transcription in the vasculature and impaired vascular nitric oxide synthesis. These problems translated into vascular
dysfunction and arterial hypertension (Panel C).
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Figure 3
Flow-mediated vasodilation (FMD) of the brachial artery and right ventricular to right atrial (RV-RA) pressure gradient in children conceived by
assisted reproductive technologies (ART), in offspring of mothers suffering from preeclampsia and in age- and gender-matched healthy control
children (Panel A and B). FMD and pulse wave velocity (PWV) in fertile parents of control children and of sterile parents ART children (Panel C
and D). Relationship between maternal age and FMD in ART children (Panel E). FMD in control children, ART children and children naturally
conceived during stimulation of the ovulation in the mother (Panel F). Data are expressed as mean ± SEM. ANOVA and Bonferroni post-doc test
(for Panel A, B and F).
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Figure 4
Vascular function and arterial blood pressure in mice generated by ART and control mice. Panel A shows acetylcholine-induced mesenteric
artery vasodilation, Panel B the carotid artery pressure-diameter relationship, a proxy of vascular stiffness, Panel C shows mean arterial blood
pressure obtained by telemetry. Panel D shows acetylcholine-induced mesenteric artery vasodilation in mice conceived during stimulation of the
ovulation in the mother and control mice.
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Figure 5
Potential factors involved in the development of ART-induced vascular alterations. Parental and procedure-associated factors that seem not to
be major determinants of vascular changes are marked in green, procedure-associated factors that may play a major role in red.
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